CLINICAL STUDY: ATRIAL FIBRILLATION
Clinical value of left atrial appendage flow for prediction of long-term sinus rhythm maintenance in patients with nonvalvular atrial fibrillation
Emanuele Antonielli, MD*,
Alfredo Pizzuti, MD ,
Attila Pálinkás, MD ,
Mattia Tanga, MD*,
N. oèmi Gruber, MD ,
Claudio Michelassi, BSc ,
Albert Varga, MD ,
Alessandro Bonzano, MD ,
Nicola Gandolfo, MD ,
L.ászló Halmai, MD ,
Antonia Bassignana, MD*,
Muhammad Babar Imran, MD ,
Fabrizio Delnevo, MD ,
Miklós Csanády, MD and
Eugenio Picano, MD, PhD ,*
* Divisione di Cardiologia, Ospedale SS. Annunziata, Savigliano, Italy
Divisione di Cardiologia, Ospedale Mauriziano, Umberto I, Torino, Italy
Second Department of Medicine and Cardiology Center, Albert Szent-Györgyi Medical Faculty, University of Sciences, Szeged, Hungary
National Research Council, Consiglio Nazionale delle Ricerche, Institute of Clinical Physiology, Pisa, Italy
Manuscript received June 6, 2001;
revised manuscript received January 31, 2002,
accepted February 8, 2002.
* Reprint requests and correspondence: Dr. Eugenio Picano, Institute of Clinical Physiology, Pisa, CNR, Via Moruzzi, 1, 56100 Pisa, Italy. picano{at}ifc.cnr.it
OBJECTIVES: This study evaluated the role of various clinical and echocardiographic parameters, including the left atrial appendage (LAA) anterograde flow velocity, for prediction of the long-term preservation of sinus rhythm (SR) in patients with successful cardioversion (CV) of nonvalvular atrial fibrillation (AF).
BACKGROUND: Echocardiographic parameters for assessing long-term SR maintenance after successful CV of nonvalvular AF are not accurately defined.
METHODS: Clinical, transthoracic echocardiographic and transesophageal echocardiographic (TEE) datameasured in AF lasting >48 hof 186 consecutive patients (116 men, mean age: 65 ± 9 years) with successful CV (electrical or pharmacologic) were analyzed for assessment of one-year maintenance of SR.
RESULTS: At one-year follow-up, 91 of 186 (49%) patients who underwent successful CV continued to have SR. Mean LAA peak emptying flow velocity was higher in patients remaining in SR for one year than in those with AF relapse (41.7 ± 20.2 cm/s vs. 27.7 ± 17.0 cm/s; p < 0.001). On multivariate logistic regression analysis, only the mean LAA peak emptying velocity >40 cm/s (p = 0.0001; 2: 23.9, odds ratio [OR] = 5.2, confidence interval [CI] 95% = 2.7 to 10.1) and the use of preventive antiarrhythmic drug treatment (p = 0.0398; 2: 4.2; OR = 2.0, CI 95% = 1.0 to 3.8) predicted the continuous preservation of SR during one year, outperforming other univariate predictors such as absence of left atrial spontaneous echocardiographic contrast during TEE, the left atrial parasternal diameter <44 mm, left ventricular ejection fraction >46% and AF duration <1 week before CV. The negative and positive predictive values of the mean LAA peak emptying velocity >40 cm/s for assessing preservation of SR were 66% (CI 95% = 56.9 to 74.2) and 73% (CI 95% = 62.4 to 83.3), respectively.
CONCLUSIONS: In TEE-guided management of nonvalvular AF, high LAA flow velocity identifies patients with greater likelihood to remain in SR for one year after successful CV. Low LAA velocity is of limited value in identifying patients who will relapse into AF.
|
Abbreviations and Acronyms
| | AF | | atrial fibrillation | | CI | | confidence interval | | CV | | cardioversion | | ECG | | electrocardiogram | | LA | | left atrial | | LAA | | left atrial appendage | | LV | | left ventricular | | OR | | odds ratio | | ROC | | receiver-operating characteristic | | SR | | sinus rhythm | | TEE | | transesophageal echocardiography/echocardiographic | | TTE | | transthoracic echocardiography/echocardiographic |
|
This article has been cited by other articles:

|
 |

|
 |
 
D. E. Singer, G. W. Albers, J. E. Dalen, M. C. Fang, A. S. Go, J. L. Halperin, G. Y. H. Lip, and W. J. Manning
Antithrombotic Therapy in Atrial Fibrillation: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)
Chest,
June 1, 2008;
133(6_suppl):
546S - 592S.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R I Dewar, G Y H Lip, and on behalf of the Guidelines Development Group for
Identification, diagnosis and assessment of atrial fibrillation
Heart,
January 1, 2007;
93(1):
25 - 28.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Holmqvist, M. Stridh, J. E.P. Waktare, L. Sornmo, S. B. Olsson, and C. J. Meurling
Atrial fibrillatory rate and sinus rhythm maintenance in patients undergoing cardioversion of persistent atrial fibrillation
Eur. Heart J.,
September 2, 2006;
27(18):
2201 - 2207.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Strandberg, M.J. P. Raatikainen, M. Niemela, M. Luotolahti, J. Hartiala, and K.E. J. Airaksinen
Clinical practicality and predictive value of transoesophageal echocardiography in early cardioversion of atrial fibrillation
Europace,
June 1, 2006;
8(6):
408 - 412.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. D. Hoit
Assessing Atrial Mechanical Remodeling and Its Consequences
Circulation,
July 19, 2005;
112(3):
304 - 306.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M R M Jongbloed, M J Schalij, K Zeppenfeld, P V Oemrawsingh, E E van der Wall, and J J Bax
Clinical applications of intracardiac echocardiography in interventional procedures
Heart,
July 1, 2005;
91(7):
981 - 990.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. R. Engel and S. K. Topalian
The Pathology of Lone Atrial Fibrillation
Chest,
February 1, 2005;
127(2):
424 - 425.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. A. Paraskevaidis, T. Dodouras, D. Tsiapras, and D. T. Kremastinos
Prediction of Successful Cardioversion and Maintenance of Sinus Rhythm in Patients With Lone Atrial Fibrillation
Chest,
February 1, 2005;
127(2):
488 - 494.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. E. Singer, G. W. Albers, J. E. Dalen, A. S. Go, J. L. Halperin, and W. J. Manning
Antithrombotic Therapy in Atrial Fibrillation: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy
Chest,
September 1, 2004;
126(3_suppl):
429S - 456S.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. L. McNamara, L. J. Tamariz, J. B. Segal, and E. B. Bass
Management of Atrial Fibrillation: Review of the Evidence for the Role of Pharmacologic Therapy, Electrical Cardioversion, and Echocardiography
Ann Intern Med,
December 16, 2003;
139(12):
1018 - 1033.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|